| Bruce J Bortnick, MD | |
|
20410 Observation Dr, Suite 104, Germantown, MD 20876-4000 | |
| (301) 948-5700 | |
| (301) 212-4277 |
| Full Name | Bruce J Bortnick |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 45 Years |
| Location | 20410 Observation Dr, Germantown, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740251271 | NPI | - | NPPES |
| 920601901 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | D25665 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Healthcare Shady Grove Medical Center | Rockville, MD | Hospital |
| Adventist Healthcare White Oak Medical Center | Silver spring, MD | Hospital |
| Adventist Healthcare Fort Washington Medical Ctr | Fort washington, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blackwell Physicians, Llc | 2163810383 | 28 |
News Archive
A landmark report released today by the Institute of Medicine provides powerful new evidence that elected officials have no excuse for failing to enact comprehensive smoke-free workplace laws. The IOM report concludes smoke-free laws reduce the number of heart attacks and save lives. The report also confirms that there is conclusive scientific evidence that secondhand smoke causes heart disease, including heart attacks, and finds there is compelling evidence that even relatively brief exposure to secondhand smoke can lead to a heart attack.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
Health experts continue to react to the CIA's use of a vaccine campaign to hunt Osama bin Laden:
InnaVirVax, a biopharmaceutical company specialized in research and development on therapeutic and diagnostic solutions for diseases linked to immune dysregulation, has just announced successful completion of the first clinical development phase for VAC-3S immunotherapy in the treatment of HIV infections.
Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announced today a partnership agreement to distribute the company's breast cancer recurrence assay, MammaPrint, in the Middle East.
› Verified 5 days ago
| Entity Name | Medical Faculty Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417990581 PECOS PAC ID: 4082528898 Enrollment ID: O20031117000341 |
News Archive
A landmark report released today by the Institute of Medicine provides powerful new evidence that elected officials have no excuse for failing to enact comprehensive smoke-free workplace laws. The IOM report concludes smoke-free laws reduce the number of heart attacks and save lives. The report also confirms that there is conclusive scientific evidence that secondhand smoke causes heart disease, including heart attacks, and finds there is compelling evidence that even relatively brief exposure to secondhand smoke can lead to a heart attack.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
Health experts continue to react to the CIA's use of a vaccine campaign to hunt Osama bin Laden:
InnaVirVax, a biopharmaceutical company specialized in research and development on therapeutic and diagnostic solutions for diseases linked to immune dysregulation, has just announced successful completion of the first clinical development phase for VAC-3S immunotherapy in the treatment of HIV infections.
Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announced today a partnership agreement to distribute the company's breast cancer recurrence assay, MammaPrint, in the Middle East.
› Verified 5 days ago
| Entity Name | Blackwell Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932772589 PECOS PAC ID: 2163810383 Enrollment ID: O20211021001344 |
News Archive
A landmark report released today by the Institute of Medicine provides powerful new evidence that elected officials have no excuse for failing to enact comprehensive smoke-free workplace laws. The IOM report concludes smoke-free laws reduce the number of heart attacks and save lives. The report also confirms that there is conclusive scientific evidence that secondhand smoke causes heart disease, including heart attacks, and finds there is compelling evidence that even relatively brief exposure to secondhand smoke can lead to a heart attack.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
Health experts continue to react to the CIA's use of a vaccine campaign to hunt Osama bin Laden:
InnaVirVax, a biopharmaceutical company specialized in research and development on therapeutic and diagnostic solutions for diseases linked to immune dysregulation, has just announced successful completion of the first clinical development phase for VAC-3S immunotherapy in the treatment of HIV infections.
Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announced today a partnership agreement to distribute the company's breast cancer recurrence assay, MammaPrint, in the Middle East.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bruce J Bortnick, MD 20410 Observation Dr, Suite 104, Germantown, MD 20876-4000 Ph: (301) 948-5700 | Bruce J Bortnick, MD 20410 Observation Dr, Suite 104, Germantown, MD 20876-4000 Ph: (301) 948-5700 |
News Archive
A landmark report released today by the Institute of Medicine provides powerful new evidence that elected officials have no excuse for failing to enact comprehensive smoke-free workplace laws. The IOM report concludes smoke-free laws reduce the number of heart attacks and save lives. The report also confirms that there is conclusive scientific evidence that secondhand smoke causes heart disease, including heart attacks, and finds there is compelling evidence that even relatively brief exposure to secondhand smoke can lead to a heart attack.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
Health experts continue to react to the CIA's use of a vaccine campaign to hunt Osama bin Laden:
InnaVirVax, a biopharmaceutical company specialized in research and development on therapeutic and diagnostic solutions for diseases linked to immune dysregulation, has just announced successful completion of the first clinical development phase for VAC-3S immunotherapy in the treatment of HIV infections.
Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announced today a partnership agreement to distribute the company's breast cancer recurrence assay, MammaPrint, in the Middle East.
› Verified 5 days ago
Jonathan R Bowles, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 20410 Observation Dr, Suite 104, Germantown, MD 20876 Phone: 301-948-5700 Fax: 301-212-4277 | |
Zahide Erkmen, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 20410 Observation Dr, Suite 104, Germantown, MD 20876 Phone: 301-948-5700 Fax: 301-212-4277 | |
Akemi Miller, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 20410 Observation Dr Ste 104, Germantown, MD 20876 Phone: 301-212-4264 | |
Alka Singh, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 20528 Boland Farm Rd, Suite 110, Germantown, MD 20876 Phone: 301-428-2884 | |
Velma E Casanova, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 20410 Observation Dr, Suite 104, Germantown, MD 20876 Phone: 301-948-5700 Fax: 301-212-4277 | |
Deborah Burke, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 20410 Observation Dr, Suite 104, Germantown, MD 20876 Phone: 301-948-5700 Fax: 301-212-4277 | |
Dr. Amar Rewari, MD, MBA Radiology Medicare: Accepting Medicare Assignments Practice Location: 20330 Seneca Meadows Pkwy, Germantown, MD 20876 Phone: 301-309-6765 Fax: 301-309-2230 |